Publicacións en colaboración con investigadores/as de Universitat de Girona (21)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Downregulated Adipose Tissue Expression of Browning Genes With Increased Environmental Temperatures

    The Journal of clinical endocrinology and metabolism, Vol. 109, Núm. 1, pp. e145-e154

  3. Liver lipopolysaccharide binding protein prevents hepatic inflammation in physiological and pathological non-obesogenic conditions

    Pharmacological Research, Vol. 187

  4. Obesity wars: may the smell be with you

    American journal of physiology. Endocrinology and metabolism, Vol. 324, Núm. 6, pp. E569-E576

2022

  1. Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer's Disease

    Journal of Medicinal Chemistry, Vol. 65, Núm. 6, pp. 4909-4925

  2. Downregulation of hepatic lipopolysaccharide binding protein improves lipogenesis-induced liver lipid accumulation

    Molecular Therapy - Nucleic Acids, Vol. 29, pp. 599-613

  3. Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study

    Nutrients, Vol. 14, Núm. 1

  4. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  5. Synthesis, In Vitro Profiling, and In Vivo Evaluation of Benzohomoadamantane-Based Ureas for Visceral Pain: A New Indication for Soluble Epoxide Hydrolase Inhibitors

    Journal of medicinal chemistry, Vol. 65, Núm. 20, pp. 13660-13680

2021

  1. BMP8 and activated brown adipose tissue in human newborns

    Nature Communications, Vol. 12, Núm. 1

  2. From the Design to the in Vivo Evaluation of Benzohomoadamantane-Derived Soluble Epoxide Hydrolase Inhibitors for the Treatment of Acute Pancreatitis

    Journal of Medicinal Chemistry, Vol. 64, Núm. 9, pp. 5429-5446

  3. Nicotine’ actions on energy balance: Friend or foe?

    Pharmacology and Therapeutics, Vol. 219

2020

  1. 2-Oxaadamant-1-yl Ureas as Soluble Epoxide Hydrolase Inhibitors: In Vivo Evaluation in a Murine Model of Acute Pancreatitis

    Journal of medicinal chemistry, Vol. 63, Núm. 17, pp. 9237-9257

  2. Genetic variants of uncertain significance: How to match scientific rigour and standard of proof in sudden cardiac death?

    Legal Medicine, Vol. 45

2019

  1. Sudden infant death as the most severe phenotype caused by genetic modulation in a family with atrial fibrillation

    Forensic Science International: Genetics, Vol. 43

2017

  1. The gut metagenome changes in parallel to waist circumference, brain iron deposition, and cognitive function

    Journal of Clinical Endocrinology and Metabolism, Vol. 102, Núm. 8, pp. 2962-2973

2016

  1. Proteomic identification of putative biomarkers for early detection of sudden cardiac death in a family with a LMNA gene mutation causing dilated cardiomyopathy

    Journal of Proteomics, Vol. 148, pp. 75-84

2015

  1. Genetic analysis of arrhythmogenic diseases in the era of NGS: The complexity of clinical decision-making in Brugada Syndrome

    PLoS ONE, Vol. 10, Núm. 7

  2. Screening of repetitive motifs inside the genome of the flat oyster (Ostrea edulis): Transposable elements and short tandem repeats

    Marine Genomics, Vol. 24, pp. 335-341

2014

  1. Sequenom MassARRAY approach in the arrhythmogenic right ventricular cardiomyopathy post-mortem setting: clinical and forensic implications

    International Journal of Legal Medicine, Vol. 129, Núm. 1